Show simple item record

dc.contributor.authorAardoom, MA
dc.contributor.authorKlomberg, RCW
dc.contributor.authorKemos, P
dc.contributor.authorRuemmele, FM
dc.contributor.authorvan Ommen, H
dc.contributor.authorde Ridder, L
dc.contributor.authorCroft, NM
dc.date.accessioned2021-10-12T14:30:53Z
dc.date.available2021-10-12T14:30:53Z
dc.date.issued2021-10-02
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/74494
dc.description.abstractBACKGROUND & AIMS: Guidelines regarding thromboprophylaxis for venous thromboembolisms (VTE) in children with inflammatory bowel disease (IBD) are based on limited paediatric evidence. We aimed to prospectively assess the incidence of VTE in paediatric-onset IBD (PIBD), characterize PIBD patients with VTE, and identify potential IBD-related risk factors. METHODS: From October 2016 till September 2020, paediatric gastroenterologists prospectively replied to the international Safety Registry, monthly indicating whether they had observed a VTE case in a patient <19 years with IBD. IBD details (type, Paris classification, clinical and biochemical disease activity, treatment) and VTE details (type, location, treatment, outcome) were collected. To estimate the VTE incidence, participants annually reported the number of PIBD patients, data source and catchment area of their center. A systematic literature review and meta-analysis was performed to calculate the VTE incidence in the general paediatric population. RESULTS: Participation of 129 PIBD centers resulted in coverage of 24,802 PIBD patients. Twenty cases of VTE were identified (30% Crohn's disease). The VTE incidence was 3.72 [95%CI 2.27 - 5.74] per 10,000 person-years, 14-fold higher than in the general paediatric population (0.27 [95%CI 0.18-0.38], p<0.001). Cerebral sinus venous thrombosis was most frequently reported (50%). All but one patient had active IBD, 45% were using steroids and 45% hospitalized. No patient received thromboprophylaxis, whereas according to current PIBD guidelines, this was recommended in 4/20 patients. CONCLUSION: There is an increased risk of VTE in the PIBD population compared to the general paediatric population. Awareness of VTE occurrence and prevention should be extended to all PIBD patients with active disease, especially those hospitalized.en_US
dc.languageeng
dc.relation.ispartofJ Crohns Colitis
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subjectCrohn’s diseaseen_US
dc.subjectcomplicationen_US
dc.subjectextra-intestinal manifestationen_US
dc.subjectpaediatricen_US
dc.subjectulcerative colitisen_US
dc.titleThe incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry.en_US
dc.typeArticleen_US
dc.identifier.doi10.1093/ecco-jcc/jjab171
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/34599822en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial 3.0 United States